Thus, the presence of EGFR and MET on the surfaces of tumor cells enables immune effector cell-mediated cell destruction, macrophages, and natural killer cells through mechanisms of antibody-dependent cellular cytotoxicity and trogocytosis, respectively [9]. Figure 1 illustrates the mechanism of action of amivantamab [10]. Here, EGFR is linked to neoplasm.